secwatch.observer — SEC 8-K summary
======================================

Issuer:     HilleVax, Inc. (—)
CIK:        0001888012
Form:       8-K
Filed at:   2025-09-17T23:59:59+00:00
Accession:  0001193125-25-205570
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.95
Item codes: 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HilleVax acquired by XOMA Royalty for $1.95/share plus CVR; delisted from Nasdaq
--------------------------------------------------------------------------------

- 39,214,689 shares (77.48% of outstanding) validly tendered; minimum condition satisfied.
- Shareholders receive $1.95 cash per share plus one non-transferable CVR for future payments.
- CVR entitles holders to 90% of net proceeds from Legacy Assets (HIL-216, Kangh License) and net cash adjustments.
- All directors and officers (CEO Hershberg, CFO Maltbie) ceased; Merger Sub directors and officers assumed roles.
- Nasdaq delisting effective Sept 17, 2025; Form 15 to be filed to deregister shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1888012/000119312525205570/0001193125-25-205570-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1888012/000119312525205570/d91297d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-205570

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer